AI Engineer

About the role

OUR MISSION

Every day, people are waiting for a diagnosis, for a treatment, for a chance. Our mission is to help life-saving treatments reach patients faster.

That isn’t an abstraction to us. It’s the reason Unlearn exists, and it’s why the pace and rigor of our work matter so much.

WHAT WE DO

Unlearn is transforming clinical development by making every trial smarter. We partner with biopharmaceutical companies to redesign how clinical trials are planned, conducted, and analyzed. We use data, AI, and digital twins to make studies faster and more robust.

A digital twin is a comprehensive prediction of a patient’s expected outcomes under a defined standard of care. It is generated by machine learning models built on our proprietary technology. Leading pharma and biotech companies trust us to deliver scientifically rigorous work on studies where the stakes are high and the timelines impact patients.

WHERE WE’RE GOING

Our goal is to become the gold standard for AI-driven clinical development. Getting there takes disciplined execution and data, models, and AI that is implemented with partners using a strong engineering foundation that holds up in a regulated, compliance-heavy environment. We’re building durable advantages rooted in science and innovative technologies, and that foundation is what will make our leadership last.

OUR VALUES

Accountability, Agility, and Acceleration describe how we work with each other every day. Fulfilling our mission depends on all of us doing our best work, and it’s on all of us to build and protect the culture that makes that possible.

Accountability: We own outcomes, not just tasks We take responsibility for results, make decisions with urgency, and follow through on our commitments. When things don’t go as planned, we say so. We surface issues early, learn, iterate quickly, and move forward without blame. We give and receive feedback that is clear, direct, and actionable.

Agility: We follow the evidence Drug development and AI evolve rapidly. We stay curious, embrace new information, and change course when the evidence changes. We keep a close eye on where the industry is heading and build technology flexible enough to adapt when new data or opportunities arise. We value speed of learning over being right.

Acceleration: We create momentum Our mission is to accelerate the development of new medicines, and that starts with how we work. We simplify, prioritize, and execute with urgency. Unlearners own the problems in front of them and are empowered to solve them. That helps our customers, our teammates, and our company move faster without sacrificing scientific rigor.

ABOUT UNLEARN

Unlearn was founded in 2017 by a team of world-class machine learning scientists and is headquartered in San Francisco. We’re backed by top-tier investors including Altimeter, Insight Partners, Radical Ventures, 8VC, and DCVC. We have substantially advanced AI technology for clinical trials, including regulatory-grade applications, and are embedded in multiple clinical trials with top Pharma and Biotech companies.